Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Obesity is associated with a state of chronic, low-grade inflammation characterized by abnormal cytokine production and macrophage infiltration into adipose tissue, which may contribute to the development of insulin resistance. During immune responses, tissue infiltration by macrophages is dependent on the expression of osteopontin, an extracellular matrix protein and proinflammatory cytokine that promotes monocyte chemotaxis and cell motility. In the present study, we used a murine model of diet-induced obesity to examine the role of osteopontin in the accumulation of adipose tissue macrophages and the development of insulin resistance during obesity. Mice exposed to a high-fat diet exhibited increased plasma osteopontin levels, with elevated expression in macrophages recruited into adipose tissue. Obese mice lacking osteopontin displayed improved insulin sensitivity in the absence of an effect on diet-induced obesity, body composition, or energy expenditure. These mice further demonstrated decreased macrophage infiltration into adipose tissue, which may reflect both impaired macrophage motility and attenuated monocyte recruitment by stromal vascular cells. Finally, obese osteopontin-deficient mice exhibited decreased markers of inflammation, both in adipose tissue and systemically. Taken together, these results suggest that osteopontin may play a key role in linking obesity to the development of insulin resistance by promoting inflammation and the accumulation of macrophages in adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, the expression of osteopontin is elevated in obese adipose tissue (124)”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
In the citing paper
“and osteopontin-KO mice have reduced ATM content after HFD feeding and are protected against HFDinduced insulin resistance (124).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
In the citing paper
“and osteopontin-KO mice have reduced ATM content after HFD feeding and are protected against HFDinduced insulin resistance (124).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“As the majority of studies analyzing ATM content in murine models have used an antibody against the F4/80 antigen (3, 19), we further sought to corroborate these observations using staining for F4/80.”
BackgroundResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A host of adipose tissue–generated adipokines and cytokines have been identified that have emerged as an important source of systemic inflammation in obesity (2).”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 4×
“Based on the strong recent evidence that ATMs are both necessary and sufficient for the development of obesity-associated insulin resistance (4, 19, 43), the observed decrease in ATM content in obese OPN –/– mice provides a likely mechanism for the increased insulin sensitivity in these mice.”
BackgroundInfluentialAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425 · cited 5×
“As the majority of studies analyzing ATM content in murine models have used an antibody against the F4/80 antigen (3, 19), we further sought to corroborate these observations using staining for F4/80.”
BackgroundResultInfluentialRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 1×
“In addition, MCP-1 levels secreted from adipocytes correlate with adipocyte size (42), indicating that the MCP-1/CCR2 cascade is likely among the earliest mechanisms involved in the recruitment of monocytes to adipose tissue.”
BackgroundDiet-Induced Type II Diabetes in C57BL/6J Mice
Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A., & Feinglos, M. N. (1988) · Diabetes · doi:10.2337/diab.37.9.1163 · Cited by 1,208 · cited 1×
“HFD feeding and DIO in mice is associated with the development of insulin resistance (21), and to further explore whether insulin resistance is affected by OPN deficiency, we analyzed metabolic parameters in OPN –/– and wild-type OPN +/+ mice.”
BackgroundMonocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096 · cited 1×
“The MCP-1/C-C motif chemokine receptor 2 (MCP-1/CCR2) axis is well established to regulate macrophage recruitment to sites of inflammation (39, 40), and MCP-1 is secreted from adipocytes and plasma levels are increased in obesity (41).”
BackgroundOldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078 · cited 1×
“Since its initial cloning in 1986 (25), OPN has been associated with a remarkable range of pathologic responses (10); however, its role in obesity and metabolic disorders has not, to our knowledge, previously been investigated.”
BackgroundDenhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059 · cited 5×
“…in adipose tissue combined with recent studies characterizing OPN as an important component of cell-mediated immune responses and monocyte motility (10, 11), we investigated the expression of OPN in adipose tissue and examined the role of OPN for macrophage accumulation in adipose tissue.”
BackgroundInfluentialKamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 917
Osteopontin--a possible anchor of osteoclasts to bone.
Reinholt, F. P., Hultenby, K., Oldberg, A., & Heinegård, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4473 · Cited by 824
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 705
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Adipose Tissue-Derived Factors: Impact on Health and Disease
Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 619 · cited 1×
“Finally, we determined systemic levels of 3 adipokines that have been implicated in insulin sensitivity (23, 24).”
MethodOsteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
Yoshitake, H., Rittling, S. R., Denhardt, D. T., & Noda, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8156 · Cited by 374 · cited 2×
“OPN deficiency renders mice less sensitive to bone resorption (36, 38).”
BackgroundResultGiachelli, C. M., Lombardi, D. M., Johnson, R. J., Murry, C. E., & de Almeida, M. A. G. (1998) · Europe PMC (PubMed Central) · Cited by 370
Rollins, B., Walz, A., & Baggiolini, M. (1991) · Blood · doi:10.1182/blood.v78.4.1112.1112 · Cited by 369
Lumeng, C. N., Deyoung, S. M., & Saltiel, A. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2006 · Cited by 359
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Bruemmer, D., Collins, A. R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M. C., Blaschke, F., Kintscher, U., Graf, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18141 · Cited by 306 · cited 10×
“Consistent with our previous studies (9), there were no differences in weights between OPN –/– and OPN +/+ mice at base-line or after feeding a LFD for 25 weeks.”
BackgroundMethodResultInfluentialSelf-citationSahai, A., Malladi, P., Pan, X., Paul, R., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2004 · Cited by 290
Macrophages express osteopontin during repair of myocardial necrosis.
Murry, C. E., Giachelli, C. M., Schwartz, S. M., & Vracko, R. (1994) · PubMed · Cited by 286
Weber, G. F., Zawaideh, S., Hikita, S., Kumar, V. A., Cantor, H., & Ashkar, S. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.752 · Cited by 270
Bruemmer, D., Collins, A. R., Noh, G. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318141 · Cited by 249
Self-citationEvaluation of a Quantitative Magnetic Resonance Method for Mouse Whole Body Composition Analysis
Tinsley, F. C., Taicher, G. Z., & Heiman, M. L. (2004) · Obesity Research · doi:10.1038/oby.2004.20 · Cited by 244 · cited 5×
“Our experiments employed NMR technology to provide measures of body fat mass, fat-free mass, and water content (37).”
MethodInfluentialIshijima, M., Rittling, S. R., Yamashita, T., Tsuji, K., Kurosawa, H., Nifuji, A., Denhardt, D. T., & Noda, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.399 · Cited by 240 · cited 2×
“Thus this knowledge and the observation that bone density analyzed by micro-CT is not affected by OPN deficiency in unstressed mice (38) argues against a contribution of OPN deficiency in bone tissue to the observed decrease in lean body mass.”
BackgroundHirsch, S., Austyn, J. M., & Gordon, S. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.713 · Cited by 213 · cited 1×
“As the majority of studies analyzing ATM content in murine models previously employed an antibody raised against the F4/80 antigen (3, 19), a marker specific for mature macrophages (20), we stained consecutive sections for F4/80 and OPN.”
BackgroundOsteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice
Matsui, Y., Rittling, S. R., Okamoto, H., Inobe, M., Jia, N., Shimizu, T., Akino, M., Sugawara, T., Morimoto, J., Kimura, C., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000074878.29805.d0 · Cited by 196 · cited 1×
“Using OPN-deficient mice crossed to atherosclerosis-prone apoE –/– mice, we (9) and others (15) have further recently demonstrated that OPN deficiency attenuates the development of atherosclerosis.”
BackgroundDorheim, M., Sullivan, M., Dandapani, V., Wu, X., Hudson, J., Segarini, P. R., Rosen, D. M., Aulthouse, A. L., & Gimble, J. M. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540215 · Cited by 195 · cited 1×
“Although OPN is expressed in proliferating fibroblasts (33), these observations confirm earlier reports documenting decreased OPN mRNA levels in differentiated adipocytes as compared with pre-adipocytes (34).”
ResultA chemoattractant cytokine associated with granulomas in tuberculosis and silicosis
Nau, G. J., Guilfoile, P., Chupp, G. L., Berman, J. S., Kim, S. J., Kornfeld, H., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6414 · Cited by 190 · cited 4×
“Concomitant with the attenuated macrophage content in obese adipose tissue from OPN –/– mice, we documented decreased inflammatory gene expression in adipose tissue and decreased systemic levels of the proinflammatory cytokines IL-6, MCP-1, and PAI-1.”
BackgroundInfluentialPlasma osteopontin levels are associated with the presence and extent of coronary artery disease
Ohmori, R., Momiyama, Y., Taniguchi, H., Takahashi, R., Kusuhara, M., Nakamura, H., & Ohsuzu, F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00298-3 · Cited by 185
Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2004 · Cited by 181
Zhu, B., Suzuki, K., Goldberg, H. A., Rittling, S. R., Denhardt, D. T., McCulloch, C. A. G., & Sodek, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10394 · Cited by 172 · cited 3×
“In summary, in the present study we characterize OPN, a versatile mediator of macrophage motility involved in cell-mediated inflammation (9–11, 22, 51), as a novel cytokine expressed by ATMs and secreted during DIO.”
BackgroundA human macrophage‐associated antigen (CD68) detected by six different monoclonal antibodies
Micklem, K., Rigney, E., Cordell, J., Simmons, D., Stross, P., Turley, H., Seed, B., & Mason, D. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb00210.x · Cited by 159
Attenuated Host Resistance against Mycobacterium bovis BCG Infection in Mice Lacking Osteopontin
Nau, G. J., Liaw, L., Chupp, G. L., Berman, J. S., Hogan, B. L. M., & Young, R. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.4223-4230.1999 · Cited by 150 · cited 1×
“Finally, it is well recognized that OPN –/– mice have defective granulomatous responses (8, 46) that likely involve abnormal macrophage function.”
BackgroundElevated osteopontin levels in active relapsing‐remitting multiple sclerosis
Vogt, M. H. J., Lopatinskaya, L., Smits, M., Polman, C. H., & Nagelkerken, L. (2003) · Annals of Neurology · doi:10.1002/ana.10606 · Cited by 124
The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence.
Miyazaki, Y., Setoguchi, M., Yoshida, S., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77320-1 · Cited by 123 · cited 1×
“OPN is rapidly expressed after cellular activation, and it is abundantly secreted by activated macrophages but not resting macrophages or monocytes (31, 32).”
BackgroundOsteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response
Sato, T., Nakai, T., Tamura, N., Okamoto, S., Matsuoka, K., Sakuraba, A., Fukushima, T., Uede, T., & Hibi, T. (2005) · Gut · doi:10.1136/gut.2004.048298 · Cited by 121 · cited 1×
“OPN plasma levels are elevated in various inflammatory diseases, including atherosclerosis (26), inflammatory bowel disease (27), granulomatous inflammatory diseases (28), rheumatoid arthritis (29), and mul-Figure”
BackgroundSenger, D. R., Asch, B. B., Smith, B. D., Perruzzi, C. A., & Dvorak, H. F. (1983) · Nature · doi:10.1038/302714a0 · Cited by 108 · cited 1×
“Although OPN is expressed in proliferating fibroblasts (33), these observations confirm earlier reports documenting decreased OPN mRNA levels in differentiated adipocytes as compared with pre-adipocytes (34).”
ResultKoguchi, Y., Kawakami, K., Uezu, K., Fukushima, K., Kon, S., Maeda, M., Nakamoto, A., Owan, I., Kuba, M., Kudeken, N., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-1113oc · Cited by 104
Ogawa, D., Stone, J. F., Takata, Y., Blaschke, F., Chu, V. H., Towler, D. A., Law, R. E., Hsueh, W. A., & Bruemmer, D. (2005) · Circulation Research · doi:10.1161/01.res.0000163630.86796.17 · Cited by 104
Self-citationNyström, T., Dunér, P., & Hultgårdh‐Nilsson, A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.12.026 · Cited by 91
Oyama, Y., Akuzawa, N., Nagai, R., & Kurabayashi, M. (2002) · Circulation Research · doi:10.1161/hh0202.103229 · Cited by 64
Koyama, Y., Rittling, S. R., Tsuji, K., Hino, K., Salincarnboriboon, R., Yano, T., Taketani, Y., Nifuji, A., Denhardt, D. T., & Noda, M. (2006) · Endocrinology · doi:10.1210/en.2005-0671 · Cited by 36 · cited 1×
“Consistent with several recent stud - ies (9, 35, 36), total body weights were similar in wild-type and OPN-deficient mice.”
ResultSynovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis.
Gattorno, M., Gregorio, A., Ferlito, F., Gerloni, V., Parafioriti, A., Felici, E., Sala, E., Gambini, C., Picco, P., & Martini, A. (2004) · Rheumatology · doi:10.1093/rheumatology/keh250 · Cited by 34 · cited 1×
“OPN plasma levels are elevated in various inflammatory diseases, including atherosclerosis (26), inflammatory bowel disease (27), granulomatous inflammatory diseases (28), rheumatoid arthritis (29), and mul-Figure”
BackgroundBruemmer, D., Yin, F., Liu, J., Berger, J. P., Kiyono, T., Chen, J., Fleck, E., Herle, A. J. V., FORMAN, B. M., & Law, R. E. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0410 · Cited by 32
Self-citationSomerman, M. J., Berry, J. E., Khalkhali‐Ellis, Z., Osdoby, P., & Simpson, R. U. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1042 · Cited by 21
Research works printed but not linked: 1
- Zohar, R., et al. 2000. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell. Physiol. 184:118-130. · DOI · Paper page
Cited by
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Macrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
“For example, osteopontin — a secreted matrix glycoprotein that acts as a pro-inflammatory cytokine — promotes adipose tissue inflammation, insulin resistance and hepatic steatosi”
BackgroundInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
“These effects include the up- or down-regulation of the synthesis of resistin((138)), leptin, adiponectin((139)), lipocalin 2((140)), osteopontin((141)), and of insulin itself.”
Autophagy—a key player in cellular and body metabolism
Kim, K. H., & Lee, M.-S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.35 · Cited by 963
Metadata
- Authors
- Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E. B., Jones, K. L., Kawamori, R., Cassis, L. A., Tschöp, M. H., & Bruemmer, D.
- Affiliations
- University of Kentucky (US)
- Juntendo University (JP)
- University of Cincinnati (US)
- Corresponding author
- Bruemmer, Dennis
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-10-01
- Volume
- 117
- Issue
- 10
- Pages
- 2877-2888
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1964510
- OpenAlex
- W2096574031
- Cited by
- 401
- References
- 56
- Citations by year
- 2026: 16 · 2025: 7 · 2024: 20 · 2023: 19 · 2022: 20 · 2021: 9 · 2020: 19 · 2019: 21 · 2018: 19 · 2017: 16 · 2016: 35 · 2015: 26 · 2014: 25 · 2013: 37 · 2012: 21
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- American Diabetes Association (0725313B, 1-06-RA-17, HL084611, 0435239N)
- American Heart Association
- University of Kentucky
- National Institutes of Health (1-06-RA-17, 0435239N, 0725313B, DK 59630)
- National Heart, Lung, and Blood Institute (HL084611, R01HL084611)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, U24DK059630)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- osteopontin, obesity, adipose tissue macrophages, insulin resistance, diet-induced obesity, macrophage infiltration, monocyte recruitment, macrophage motility, low-grade inflammation, high-fat diet, stromal vascular cells
- MeSH terms
- Adipose Tissue, Animals, Chemotaxis, Dietary Fats, Inflammation, Insulin Resistance, Macrophages, Mice, Mutant Strains, Obesity, Chemokine CCL2, Mice, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.